Salix Pharmaceuticals Ltd

Historical 13F Holders

Symbol
SLXP
CUSIP
795435106
All holders as of
Q1 2016
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2016 Q1 1 417 $72.0 k
2015 Q4 1 50.0 $6.00 k
2015 Q2 1 300 $52.0 k
2015 Q1 384 62.8 M $10.8 B
2014 Q4 391 70.1 M $8.08 B
2014 Q3 393 67.9 M $10.6 B
2014 Q2 335 68.8 M $8.48 B
2014 Q1 321 65.6 M $6.79 B